Eka Ventures Closes £80 Million Fund II to Back 30 UK Startups in Health, Consumer Resilience and Decarbonisation

Eka Ventures has reached a final close of £80 million, or about $107 million, for its second fund, giving the UK-based impact venture investor a larger capital base to back early-stage companies working in health, sustainability, and consumer-focused system change. Eka said the new vehicle will support up to 30 UK-based pre-seed and seed-stage businesses, with an average first cheque of around $2 million and a plan to lead or co-lead about 90% of investments.

The close is significant because it shows continued institutional appetite for impact-focused venture strategies at a time when fundraising remains difficult for many early-stage managers. Eka also said the fund makes it the UK’s largest early-stage impact venture capital firm investing across health, wellbeing, and sustainability. That positioning matters because the firm is targeting sectors where commercial growth and measurable impact are being framed as mutually reinforcing rather than competing objectives.

 

The strategy is built around consumer-linked structural themes

 

Eka’s investment model focuses on what it describes as consumer-led mega trends across life, health, and sustainability. In practice, that means backing startups working on areas such as better access to essential products and services, preventive health technologies, and technologies that improve resource efficiency and decarbonisation across large consumer industries. The firm’s own announcement argues that the biggest commercial opportunities of the next decade will come from companies redesigning the systems people depend on, including food, health, mobility, home energy, and consumption patterns.

That thesis is notable because it places decarbonisation inside a broader consumer and systems framework rather than treating climate technology as a standalone niche. The implication is that Eka wants exposure to businesses where sustainability, affordability, and everyday demand intersect. That can potentially widen the investable market beyond specialist climate software or industrial hardware and into consumer-facing models with larger addressable markets. This broader interpretation is an inference based on Eka’s stated themes and investment focus.

 

Read more: Energy Vault Enters Japan With 850 MW Storage Portfolio as Owned Assets Top 1 GW and EBITDA Target Exceeds $180 Million

 

British Business Bank anchors the fund with half the capital

 

A key part of the story is the backing structure. The British Business Bank has committed £40 million to Fund II, representing half of the total fund size and making it a cornerstone investor in the vehicle. The Bank said the fund will focus on measurable impact and commercial ambition, backing founders whose businesses are intended to improve lives while delivering long-term economic benefit.

Other participating limited partners include Better Society Capital, Guy’s & St Thomas’ Foundation, The Health Foundation, WRAP, Esmée Fairbairn Foundation, John Ellerman Foundation, and Vivensa Foundation. That LP mix is important because it combines public capital, foundations, and mission-aligned institutions, suggesting Fund II is being positioned as a commercially oriented impact vehicle with a relatively strong alignment between capital source and investment mandate.

 

Explore OneStop ESG Marketplace: Software and Technology

 

What the close signals for the impact venture market

 

The final close suggests that the impact venture market is still able to attract meaningful capital when the investment thesis is tightly defined and tied to large economic transitions. Eka’s message is that impact and returns are not opposites, and that companies reshaping health, sustainability, and everyday economic systems will produce some of the strongest venture outcomes of the next decade. Whether that view proves correct will depend on portfolio execution, but the £80 million close indicates that a substantial set of LPs is willing to back that argument. This is an inference based on the fundraise, the LP base, and Eka’s stated thesis.

For founders, the fund adds another active UK-based source of lead capital at pre-seed and seed stage in sectors tied to preventive health, resource efficiency, and consumer decarbonisation. For the market more broadly, it shows that impact venture capital in 2026 is not only surviving as a niche. It is still scaling selectively where investors see a clear connection between structural demand shifts and venture-grade growth. This final point is an inference based on the size, strategy, and backing of Fund II.